Besides the huge potential that entering the US, European, and Asian markets that Funhaler represents,
they also have MicroEye device which is the only one of it's kind and currently or very soon to be in the hands of 20 - 25 optomitrists for clinical evaluation. MicroEye was unvieled in the States last month.
A very worthwhile read is their investor presentation put out on the 16th Feb.
VSG
visiomed group limited
